Search research articles
Contact Us
Filters
Showing results (211-220 of 244) with videos related to
Page
of 25
Sort By:
Plos One
|
March 22, 2019
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial
Axel Ducret, Ian James, Sabine Wilson, et al.
Cancer
|
January 6, 2017
Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma
Ian-James Malm, Caleb J Fan, Linda X Yin, et al.
Journal of Virology
|
October 31, 2006
Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection
Silvana Gaudieri, Andri Rauch, Lawrence P Park, et al.
Antimicrobial Agents and Chemotherapy
|
October 2, 2013
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure
Luke C Swenson, Celia K S Chui, Chanson J Brumme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2011
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc
Luke C Swenson, Theresa Mo, Winnie W Y Dong, et al.
Blood Advances
|
December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma
Ann-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Scientific Reports
|
May 24, 2018
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
Pratishtha Chatterjee, Kathryn Goozee, Chai K Lim, et al.
Frontiers in Cell and Developmental Biology
|
April 14, 2022
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, et al.
ESMO Open
|
August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.
Neurology. Genetics
|
August 6, 2020
Disease-modifying effects of an <i>SCAF4</i> structural variant in a predominantly <i>SOD1</i> ALS cohort
Julia Pytte, Loren L Flynn, Ryan S Anderton, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 244) with videos related to
Sort By:
Page
of 25
Plos One
|
March 22, 2019
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial
Axel Ducret, Ian James, Sabine Wilson, et al.
Cancer
|
January 6, 2017
Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma
Ian-James Malm, Caleb J Fan, Linda X Yin, et al.
Journal of Virology
|
October 31, 2006
Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection
Silvana Gaudieri, Andri Rauch, Lawrence P Park, et al.
Antimicrobial Agents and Chemotherapy
|
October 2, 2013
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failure
Luke C Swenson, Celia K S Chui, Chanson J Brumme, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2011
Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc
Luke C Swenson, Theresa Mo, Winnie W Y Dong, et al.
Blood Advances
|
December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphoma
Ann-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Scientific Reports
|
May 24, 2018
Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study
Pratishtha Chatterjee, Kathryn Goozee, Chai K Lim, et al.
Frontiers in Cell and Developmental Biology
|
April 14, 2022
Defects of Nutrient Signaling and Autophagy in Neurodegeneration
Jon Ondaro, Haizea Hernandez-Eguiazu, Maddi Garciandia-Arcelus, et al.
ESMO Open
|
August 20, 2019
A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer
Juan-Miguel Cejalvo, Wolfgang Jacob, Tania Fleitas Kanonnikoff, et al.
Neurology. Genetics
|
August 6, 2020
Disease-modifying effects of an <i>SCAF4</i> structural variant in a predominantly <i>SOD1</i> ALS cohort
Julia Pytte, Loren L Flynn, Ryan S Anderton, et al.
Page
of 25